参考文献/References:
[1] 梁宗英,孙光蕊,赵宝山,等.三磷酸腺苷结合盒转运子E1与P300/CBP相关因子在食管鳞癌组织中的表达及临床意义[J].陕西医学杂志,2020,49(10):1356-1358.
[2] 汤 虹,吴育锋,贾永旭,等.细胞黏附样分子L1对食管鳞状细胞癌转移的抑制作用[J].中华消化杂志,2018,38(3):158-164.
[3] 林富强,谢德耀,程德志,等.临床分期对食管癌根治手术患者生存状况的预测效果[J].中国现代医学杂志,2015,25(10):74-78.
[4] Chen YH,Lu I,Wang YM,et al.The prognostic significance of celiac lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy[J].Oncotarget,2017,8(56):96190-96202.
[5] Gurha P,Chen X,Lombardi R,et al.Knock down of plakophilin 2 downregulates miR-184 through CpG hypermethylation and suppression of the E2F1 pathway and leads to enhanced adipogenesis in vitro[J].Circ Res,2016,119(6):731-750.
[6] 张俊毅,孙志娟,李 蕾.Plakophilin2蛋白在非小细胞肺癌中的表达及其临床意义[J].中国癌症杂志,2012,22(2):125-129.
[7] Thomas W.Staging of esophageal cancer:TNM and beyond[J].Esophagus,2010,7(4):189-195.
[8] 陈龙奇.食管癌国际TNM分期第7版解读与评价[J].中华肿瘤杂志,2010,32(3):237-240.
[9] 南新记,栗广辉,王志峰.利膈散联合顺铂方案治疗食管癌效果及对患者炎性因子、生活质量和不良反应的影响[J].陕西中医,2019,40(1):58-60.
[10] 王家林,田 伟,陈耀华,等.食管鳞状细胞癌患者术前血清纤维蛋白原水平与病理特征及预后关系探讨[J].陕西医学杂志,2020,49(5):630-634.
[11] 黄显聪,赵 强,凌志强,等.EGFR mRNA上调在食管鳞状细胞癌患者预后预测中的意义[J].肿瘤学杂志,2016,22(3):199-204.
[12] Qin HD,Liao XY,Chen YB,et al.Genomic characterization of esophageal squamous cell carcinoma reveals critical genes underlying tumorigenesis and poor prognosis[J].Am J Hum Genet,2016,98(4):709-727.
[13] Wu X,Lim ZF,Li Z,et al.NORAD expression is associated with adverse prognosis in esophageal squamous cell carcinoma[J].Oncol Res Treat,2017,40(6):370-374.
[14] Jiang Y,Lo AWI,Wong A,et al.Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma[J].Oncotarget,2017,8(18):30175-30189.
[15] 王跃兵,马 琳,唐 雪,等.云南不明原因猝死病区人群PKP2基因突变研究[J].中华地方病学杂志,2019,38(2):111-116.
[16] Masic S,Brcic L,Kruslin B,et al.Expression of plakophilin 3 in diffuse malignant pleural mesothelioma[J].Histol Histopathol,2018,33(9):995-1004.
[17] Basu S,Thorat R,Dalal SN.MMP7 is required to mediate cell invasion and tumor formation upon plakophilin3 loss[J].PLoS One,2015,10(4):257-262.
[18] Campuzano O,Fernandez-Falgueras A,Iglesias A,et al.Brugada syndrome and PKP2:Evidences and uncertainties[J].Int J Cardiol,2016,225(214):403-405.
[19] Xu Y,Cai Q.Abstract 5054:Role and signaling of desmosomal DSP and PKP1 in ovarian cancer[J].Can Res,2016,76(14):5054.
[20] Fujita J,Nakajima M,Muroi H,et al.The prognostic significance of plakophilin-1 expression in esophageal cancer[J].Anticancer Res,2021,41(7):3401-3407.